dr. C.W. (Goda) Choi

Internist / Hematologist

dr. C.W. (Goda) Choi
E-mail:
c.w.choi umcg.nl

Research

Research interests

Leukemia, Lymphoma, Myeloma

Stem Cell Transplantation

Translational Research in Hematology

Publications
  1. Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

    European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties, Sellner, L., Schetelig, J., Koster, L., Choi, G., Blaise, D., Beelen, D., Schianca, F. C., Passweg, J., Schanz, U., Gyan, E., Sora, F., Kröger, N., Wulf, G. G., Van Gorkom, G., Mayer, J., Orvain, C., Bourhis, J. H., Jindra, P., Potter, V., Zallio, F., Vandenberghe, E., Robinson, S., Hayden, P. J., Yakoub-Agha, I., Montoto, S. & Dreger, P., 2020, In : Bone marrow transplantation. 4 p.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

  2. Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Poor Karnofsky Performance Status Score. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

    Saraceni, F., Labopin, M., Forcade, E., Kroger, N., Socie, G., Niittyvuopio, R., Cornelissen, J., Labussiere-Wallet, H., Blaise, D., Choi, G., Byrne, J., Guillerm, G., Lamy, T., Esteve, J., Bazarbachi, A., Savani, B., Nagler, A. & Mohty, M., Mar-2020, In : Biology of Blood and Marrow Transplantation. 26, 3 Supplement, p. S108 1 p., Abstract 147.

    Research output: Contribution to journalMeeting AbstractAcademic

  3. Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (>= 60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT

    Heinicke, T., Labopin, M., Polge, E., Niederwieser, D., Platzbecker, U., Sengelov, H., Choi, G., Cornelissen, J., Blaise, D., Kuball, J., van Gorkom, G., Schaap, N., Potter, V., Paul, F., Savani, B. N., Nagler, A. & Mohty, M., Apr-2020, In : Bone marrow transplantation. 55, 4, p. 729-739 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission

    Gorin, N., Labopin, M., Blaise, D., Choi, G., Socie, G., Bourhis, J. H., Ciceri, F., Polge, E., Nagler, A. & Mohty, M., Jul-2019, In : Bone marrow transplantation. 54, p. 564-564 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  5. TKI discontinuation after allogeneic stem cell transplantation in patients with chronic myeloid leukemia (CML): A retrospective study from the chronic malignances working party (CMWP)

    de Lavallade, H., Eikema, D-J., Hoek, J., Robin, M., Itala-Remes, M., Passweg, J., Cornelissen, J., Ganser, A., Craddock, C., Aljurf, M., Choi, G., Nagler, A., Kroeger, N., Browne, P., Dreger, P., Scheid, C., Verbeek, M., Finke, J., Chalandon, Y. & Yakoub-Agha, I., Jul-2019, In : Bone marrow transplantation. 54, p. 52-54 3 p.

    Research output: Contribution to journalMeeting AbstractAcademic

View all (45) »

ID: 17539823